$2.62
3.97% yesterday
Nasdaq, Dec 24, 08:17 pm CET
ISIN
US24477E1038
Symbol
DH

Definitive Healthcare Stock price

$2.62
-0.07 2.60% 1M
-1.38 34.50% 6M
-1.49 36.25% YTD
-1.51 36.56% 1Y
-8.81 77.08% 3Y
-40.67 93.95% 5Y
-40.67 93.95% 10Y
-40.67 93.95% 20Y
Nasdaq, Closing price Wed, Dec 24 2025
+0.10 3.97%
ISIN
US24477E1038
Symbol
DH

Key metrics

Basic
Market capitalization
$371.1m
Enterprise Value
$352.1m
Net debt
positive
Cash
$185.9m
Shares outstanding
141.4m
Valuation (TTM | estimate)
P/E
negative | 10.5
P/S
1.5 | 1.5
EV/Sales
1.5 | 1.4
EV/FCF
9.8
P/B
1.3
Financial Health
Equity Ratio
40.8%
Return on Equity
-93.0%
ROCE
-1.6%
ROIC
-2.1%
Debt/Equity
0.6
Financials (TTM | estimate)
Revenue
$242.3m | $246.5m
EBITDA
$26.5m | $70.4m
EBIT
$-9.6m | $58.8m
Net Income
$-188.7m | $35.3m
Free Cash Flow
$36.0m
Growth (TTM | estimate)
Revenue
-5.3% | -2.3%
EBITDA
33.5% | 152.4%
EBIT
47.8% | 703.9%
Net Income
48.2% | 108.6%
Free Cash Flow
-31.7%
Margin (TTM | estimate)
Gross
75.9%
EBITDA
10.9% | 28.6%
EBIT
-4.0%
Net
-77.9% | 14.3%
Free Cash Flow
14.9%
More
EPS
$-1.8
FCF per Share
$0.3
Short interest
8.2%
Employees
782
Rev per Employee
$320.0k
Show more

Is Definitive Healthcare a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Definitive Healthcare Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Definitive Healthcare forecast:

10x Buy
48%
10x Hold
48%
1x Sell
5%

Analyst Opinions

21 Analysts have issued a Definitive Healthcare forecast:

Buy
48%
Hold
48%
Sell
5%

Financial data from Definitive Healthcare

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
242 242
5% 5%
100%
- Direct Costs 58 58
11% 11%
24%
184 184
10% 10%
76%
- Selling and Administrative Expenses 128 128
12% 12%
53%
- Research and Development Expense 34 34
14% 14%
14%
26 26
34% 34%
11%
- Depreciation and Amortization 36 36
6% 6%
15%
EBIT (Operating Income) EBIT -9.57 -9.57
48% 48%
-4%
Net Profit -189 -189
48% 48%
-78%

In millions USD.

Don't miss a Thing! We will send you all news about Definitive Healthcare directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Definitive Healthcare Stock News

Neutral
Seeking Alpha
about 2 months ago
Definitive Healthcare Corp. ( DH ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Jonathan Paris - Chief Legal Officer & Secretary Kevin Coop - CEO & Director Casey Heller - Chief Financial Officer Conference Call Participants Jared Haase - William Blair & Company L.L.C., Research Division Nishad Patwardhan - Goldman Sachs Group, Inc., Research Division Johnathan McCary...
Neutral
GlobeNewsWire
about 2 months ago
FRAMINGHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended September 30, 2025.
Neutral
GlobeNewsWire
2 months ago
FRAMINGHAM, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its third quarter ended September 30, 2025, on Thursday, November 6, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET...
More Definitive Healthcare News

Company Profile

Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. Its solution offers information on healthcare providers and their activities to help the customers optimize from product development to go-to-market planning, sales, and marketing execution. The company was founded by Jason Kranzt in February 2011 and is headquartered in Framingham, MA.

Head office United States
CEO Kevin Coop
Employees 782
Founded 2011
Website ir.definitivehc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today